Soluble Biomarkers with Prognostic and Predictive Value in Advanced Non-Small Cell Lung Cancer Treated with Immunotherapy

SIMPLE SUMMARY: Immunotherapy, most notably immune checkpoint inhibitors (ICIs), has revolutionized the treatment of advanced non-small cell lung cancer (NSCLC). Although some patients respond well to ICIs, many patients do not benefit from ICIs, leading to disease progression and/or immune-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Honrubia-Peris, Beatriz, Garde-Noguera, Javier, García-Sánchez, Jose, Piera-Molons, Nuria, Llombart-Cussac, Antonio, Fernández-Murga, María Leonor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428366/
https://www.ncbi.nlm.nih.gov/pubmed/34503087
http://dx.doi.org/10.3390/cancers13174280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428366/
https://www.ncbi.nlm.nih.gov/pubmed/34503087
http://dx.doi.org/10.3390/cancers13174280

Ejemplares similares